Microbix Biosystems Statistics

Total Valuation

Microbix Biosystems has a market cap or net worth of CAD 45.80 million. The enterprise value is 39.64 million.

Market Cap	45.80M
Enterprise Value	39.64M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	n/a

Share Statistics

Microbix Biosystems has 136.70 million shares outstanding. The number of shares has decreased by -0.36% in one year.

Shares Outstanding	136.70M
Shares Change (YoY)	-0.36%
Shares Change (QoQ)	+1.11%
Owned by Insiders (%)	15.42%
Owned by Institutions (%)	0.40%
Float	115.62M

Valuation Ratios

The trailing PE ratio is 11.33 and the forward PE ratio is 16.75.

PE Ratio	11.33
Forward PE	16.75
PS Ratio	1.93
PB Ratio	1.66
P/FCF Ratio	24.81
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.02, with an EV/FCF ratio of 21.47.

EV / Earnings	9.76
EV / Sales	1.66
EV / EBITDA	16.02
EV / EBIT	28.90
EV / FCF	21.47

Financial Position

The company has a current ratio of 6.64, with a Debt / Equity ratio of 24.19.

Current Ratio	6.64
Quick Ratio	4.66
Debt / Equity	24.19
Debt / EBITDA	2.71
Debt / FCF	3.64
Interest Coverage	1.52

Financial Efficiency

Return on equity (ROE) is 15.89% and return on invested capital (ROIC) is 2.66%.

Return on Equity (ROE)	15.89%
Return on Assets (ROA)	2.41%
Return on Capital (ROIC)	2.66%
Revenue Per Employee	238,352
Profits Per Employee	40,613
Employee Count	100
Asset Turnover	0.67
Inventory Turnover	1.67

Taxes

Income Tax	-5
Effective Tax Rate	-0.00%

Stock Price Statistics

The stock price has increased by +1.52% in the last 52 weeks. The beta is 0.32, so Microbix Biosystems's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	+1.52%
50-Day Moving Average	0.33
200-Day Moving Average	0.34
Relative Strength Index (RSI)	59.30
Average Volume (20 Days)	49,774

Short Selling Information

The latest short interest is 11,447, so 0.01% of the outstanding shares have been sold short.

Short Interest	11,447
Short Previous Month	4,761
Short % of Shares Out	0.01%
Short % of Float	0.01%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Microbix Biosystems had revenue of CAD 23.84 million and earned 4.06 million in profits. Earnings per share was 0.03.

Revenue	23.84M
Gross Profit	12.96M
Operating Income	1.37M
Pretax Income	4.06M
Net Income	4.06M
EBITDA	2.30M
EBIT	1.37M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 12.87 million in cash and 6.72 million in debt, giving a net cash position of 6.16 million or 0.05 per share.

Cash & Cash Equivalents	12.87M
Total Debt	6.72M
Net Cash	6.16M
Net Cash Per Share	0.05
Equity (Book Value)	27.76M
Book Value Per Share	0.20
Working Capital	20.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.85 million and capital expenditures -1.01 million, giving a free cash flow of 1.85 million.

Operating Cash Flow	2.85M
Capital Expenditures	-1.01M
Free Cash Flow	1.85M
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 54.38%, with operating and profit margins of 5.76% and 17.04%.

Gross Margin	54.38%
Operating Margin	5.76%
Pretax Margin	17.04%
Profit Margin	17.04%
EBITDA Margin	9.64%
EBIT Margin	5.76%
FCF Margin	7.74%

Dividends & Yields

Microbix Biosystems does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.36%
Shareholder Yield	0.36%
Earnings Yield	8.83%
FCF Yield	4.03%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a